Long-Term Liabilities: The sum of all non-current liabilities.
ABVC BioPharma, Inc. (ABVC) had Long-Term Liabilities of $1.60M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-7.91M |
|
-- |
|
-- |
|
$7.15M |
|
$-7.15M |
|
$-1.20M |
|
$-8.35M |
|
$-7.36M |
|
$-8.38M |
|
$-8.38M |
|
$-8.38M |
|
$-7.38M |
|
$-7.15M |
|
$-6.65M |
|
20.11M |
|
20.11M |
|
$-0.39 |
|
$-0.39 |
|
| Balance Sheet Financials | |
$2.50M |
|
$12.84M |
|
$18.56M |
|
$21.06M |
|
$6.16M |
|
-- |
|
|
Long-Term Liabilities |
$1.60M |
$7.76M |
|
$13.30M |
|
$13.30M |
|
$13.30M |
|
24.32M |
|
| Cash Flow Statement Financials | |
$-2.99M |
|
$-1.21M |
|
$4.64M |
|
$0.86M |
|
$1.33M |
|
$0.46M |
|
$4.14M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.41 |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.99M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-63.00% |
|
-63.00% |
|
-39.77% |
|
-63.00% |
|
$0.55 |
|
$-0.15 |
|
$-0.15 |
|